Glen Eagle Advisors »

Prime Medicine shares owned by Glen Eagle Advisors

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Glen Eagle Advisors from 13F filings

Historical chart of Glen Eagle Advisors investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Glen Eagle Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Glen Eagle Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $35k 10k 3.47

More positions owned by Glen Eagle Advisors

Wisdomtree Tr Us Qtly Div Grt (DGRW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Bny Mellon Etf Trust Core Bond Etf (BKAG)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Vest Buffered (BUFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Johnson & Johnson (JNJ)
Proshares Tr S&p 500 Dv Arist (NOBL)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Innovator Etfs Trust Defined Wlt Shld (BALT)
Wal-Mart Stores (WMT)
Broadcom (AVGO)

View all positions for Glen Eagle Advisors

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
ARK Investment Management
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
Geode Capital Management
UBS Group
D. E. Shaw & Co

View all funds holding Prime Medicine